# NEUROTECH COSTBOOK

**Decision edition · model date 7 October 2026 · USD unless explicitly marked**

This document is for **pre-quote budgeting**. It is designed to answer five questions fast:

1. How much cash do I need before the next decision gate?
2. How much internal labor is really being consumed?
3. Which numbers are current prices, dated benchmarks, or assumptions?
4. What 2–3 things can move the budget materially?
5. What exact quote should I request next?

A number that is not in a scenario total is still useful only when it has a clear status and replacement path.

## 1. Decision Snapshot

| Scenario | Minimum credible cash | Base cash | Downside cash | Internal labor value | Conditional cash | Decision use |
|---|---:|---:|---:|---:|---:|---|
| Garage / dorm prototype | **$2.15k** | **$2.20k** | **$2.27k** | **$15.4k–$18.4k** for base hours | Shipping + extra iteration | Fund first useful EEG signal |
| University research EEG | **$4.5k access** or **$11.4k buy** | **$13.9k buy** | **$16.4k buy** | **$23.1k** buy path | Service/setup terms | Buy vs facility access |
| University tES + EEG | **$8.9k** | **$11.4k** | **$14.0k** hardware range | **$25.0k** base; **$38.4k** downside | Current tES configuration + safety scope | Feasibility before human study |
| 20-completer EEG pilot | **$7.4k** | **$7.5k** | **$7.6k** | **$12.8k–$15.2k** burden band | **$12.4k–$25.4k** insurance + external-recruitment branches | Early human-data funding envelope |
| U.S. 510(k) neurodiagnostic | **$467k** if small-business eligible | **$489k** standard-fee path | **$589k** if testing proxy doubles | **$52.2k** | **$0.5M–$1.5M** clinical branch | Regulatory financing decision |

**Important:** these are different economic views, not interchangeable “project cost” numbers. Cash is spend. Internal labor is economic value. Conditional cash is not included in base cash. The 510(k) model is intentionally a workstream proxy built from dated benchmarks plus the current FDA fee; it is not a universal market quote.

## 2. What You Can Budget Today

### Current primary prices

| Item | Current amount | What it actually means |
|---|---:|---|
| OpenBCI Ultracortex Mark IV | **from $499.99** | Starting vendor price; configured builds can cost more. **[A01 / S03]** |
| OpenBCI Cyton 8-channel | **$1,249** | 8-channel board list price. **[A02 / S02]** |
| OpenBCI Cyton + Daisy 16-channel | **$2,499** | 16-channel board pair list price. **[A03 / S01]** |
| OpenBCI EEG Electrode Cap Kit | **$999.99** | Current vendor cap-kit price. **[A04 / S04]** |
| Digilent Analog Discovery 3 | **$379** | Current bench instrument price. **[A05 / S05]** |
| Gold cup electrodes | **$44.99 / 10** | Current vendor electrode-pack price. **[A06 / S07]** |
| Dry EEG comb electrodes | **$49.99 / 30** | Current vendor pack price. **[A07 / S09]** |
| Cap gel | **$24.99** | Current vendor consumable price. **[A08 / S08]** |
| Muse 2 | **€269.99** | Current EU price; intentionally not converted into USD. **[A09 / S06]** |

### Current regulatory and institutional anchors

| Item | Amount | Scope |
|---|---:|---|
| FDA FY2027 510(k) small business | **$7,163** | Current FY2027 filing fee; eligibility required. **[A32 / S22]** |
| FDA FY2027 510(k) standard | **$28,653** | Current FY2027 filing fee. **[A33 / S22]** |
| FDA FY2027 establishment registration | **$13,785/year** | Separate fee where the organization's status/timing triggers it; not in the base 510(k) total. **[A34 / S22]** |
| WVU EEG compensation proxy | **$40–$50 / 60 min** | Study-specific participant compensation examples. **[A18 / S14]** |
| CUNY EEG access | **$75/hour** | External-academic facility rate effective 1 July 2025; institution-specific. **[A16 / S12]** |
| Stanford industry IRB initial review | **$3,500** | 2026 fee for specified industry-sponsored clinical trials; not a universal IRB fee. **[A17 / S13]** |

### Dated but still useful research-hardware anchors

A 2024 published review reports these ranges for research hardware. They are **not current quotes**:

| System | Published range | Budget interpretation |
|---|---:|---|
| BioSemi ActiveTwo | **$30k–$60k+** | Commercial research EEG tier. **[A10 / S25]** |
| actiCHamp | **$25k–$50k** | Commercial research EEG tier. **[A11 / S25]** |
| BrainAmp | **$20k–$30k** | Commercial research EEG tier. **[A12 / S25]** |
| g.USBamp | **$10k–$20k** | Commercial research EEG tier. **[A13 / S25]** |
| NeuroElectrics Enobio 32 | **$10k–$15k** | 32-channel research EEG proxy. **[A14 / S25]** |
| NeuroElectrics StarStim 8 | **$5k–$10k** | tES proxy only. Current Neuroelectrics product page is quote-based. **[A15 / S25 + S35]** |

### Labor anchors

BLS May 2025 national medians are used as transparent wage proxies, not startup or contractor quotes. The loaded-rate factor is **1.30–1.55**, with a central factor of **1.4287** derived from June 2026 private-industry total compensation divided by wages. The factor is a planning model, not a BLS role-specific burden rate.

| Role | Raw hourly proxy | Loaded planning band |
|---|---:|---:|
| Biomedical engineer | **$52.58/h** | **$68.35–$81.50/h** |
| Electrical engineer | **$58.00/h** | **$75.40–$89.90/h** |
| Software developer | **$65.38/h** | **$85.00–$101.34/h** |
| Project management specialist | **$49.19/h** | **$63.95–$76.24/h** |

**Interpretation:** a founder can have much lower incremental cash if they self-perform work, while the economic value of that time remains real. For a grant or resource-allocation decision, keep the two views separate.

## 3. Scenario Costbooks

## A. Garage / dorm prototype

**Decision:** Can I buy enough hardware and spend enough engineering time to reach a first useful EEG signal without building a formal lab?

### Scope contract

**Included:** current OpenBCI starting hardware, bench instrument, basic electrodes/gel, engineering labor.

**Excluded:** computer, rent, formal QMS, human subjects, clinical/regulatory work, manufacturing.

**Conditional:** shipping/tax/duties, extra rework.

**Assumed existing:** computer, bench/workspace, basic hand tools.

### Budget envelope

- Minimum credible cash: **$2,152.98**.
- Base cash: **$2,197.97**.
- Downside cash: **$2,267.95**.
- Base-hour internal labor value: **$16,951.81** at the central loaded factor.
- Same 200-hour base work at the burden band: about **$15.4k–$18.4k**.

### Cost build

| Line | Quantity | Basis | Cash |
|---|---:|---:|---:|
| Ultracortex Mark IV | 1 | $499.99 starting price | $499.99 |
| Cyton 8-channel | 1 | $1,249 | $1,249 |
| Analog Discovery 3 | 1 | $379 | $379 |
| Gold cup electrodes | 1 pack | $44.99 | $44.99 |
| Cap gel | 1 | $24.99 | $24.99 |
| **Base cash** | | | **$2,197.97** |

**Labor build:** 60 h BME + 60 h EE + 80 h software = **200 h**. Every labor line is `hours × raw wage × loaded factor`.

### What usually surprises the budget

The hardware is cheap enough that **engineering time dominates**. A second integration pass can be more expensive than a new consumable pack.

The vendor price is not the landed price. OpenBCI states shipping is calculated at checkout and customs/import/brokerage can be the customer's responsibility. A current USPS domestic small-parcel band of roughly **$9.55–$22.85** is only a carrier proxy, not an OpenBCI freight quote. **[A20 / S32]**

**To turn this into a real quote, request X from Y:** a configured OpenBCI checkout or quote for the exact SKU/size/channel configuration, ship-to ZIP, freight, tax, customs and brokerage. Save the resulting PDF or receipt.

### Sensitivity

1. **+80 software hours:** about **+$7.47k** economic cost at the base loaded software rate.
2. **Burden factor 1.30 → 1.55:** moves the 200-hour labor value from roughly **$15.4k to $18.4k**.
3. **Starting-price versus configured headset:** quote delta; do not assume the $499.99 starting price buys the configuration the project actually needs.

### Decision gate

**First useful signal:** spend the ~$2.2k hardware cash, then decide whether the next bottleneck is acquisition quality or engineering time.

### Good for

Early founder budgeting and deciding whether to prototype with low-cost EEG hardware.

### Not good for

Clinical readiness, manufacturing, formal V&V, or a regulatory financing plan.

---

## B. Serious university research EEG

**Decision:** Is a PI better off buying a dedicated 32-channel-class system or renting/accessing an existing EEG facility?

### Buy path

The 2024 Enobio 32 published range is **$10k–$15k**. Add the current **$999.99** OpenBCI cap kit and **$379** Analog Discovery 3. Result: **$11,378.99–$16,378.99 cash before shipping, tax and local setup**. **[A14 / A04 / A05]**

Base internal labor: 80 h BME + 60 h EE + 100 h software + 40 h PM = **320 h**, worth about **$23.1k** at the central loaded factor.

### Access path

CUNY's published external-academic EEG rate is **$75/hour**. Sixty facility hours = **$4,500 cash**. The same path carries about **$10.3k** internal labor for 80 h software + 40 h PM.

### Buy-vs-access screen

`buy cash / facility rate` gives a simple utilization break-even of approximately **152–218 facility hours**. This is not a full TCO: maintenance, training, downtime, support, ownership and switching costs are outside this screen.

### Sensitivity

- **+60 facility hours:** +**$4,500** cash at the CUNY proxy.
- **Amplifier tier:** moving from a 2024 Enobio proxy toward actiCHamp/ActiveTwo-class hardware can move equipment into the **$25k–$60k** range.
- **+100 labor hours:** roughly **+$8k–$9k** economic value depending on role mix.

**To turn this into a real quote, request X from Y:** a current vendor quote for the exact channel count including amplifier, cap/electrodes, acquisition/trigger, software, support, warranty, calibration and lead time.

**To turn the access proxy into a real rate, request X from Y:** the facility's current external-user rate, minimum booking block, setup/training charges, cancellation terms and after-hours rules.

### Decision gate

**Purchase gate:** buy only when expected utilization is high enough and the scientific requirement is stable enough to justify ownership.

### Good for

PI equipment decisions, grants and facility-access negotiations.

### Not good for

Clinical diagnostic procurement or an all-in institutional grant budget; F&A must be added separately using the actual institution/sponsor rules.

---

## C. University tES + EEG

**Decision:** What cash and integration effort does a research stack need before it is sensible to run a human stimulation study?

### Base build

- StarStim 8 published proxy: **$5k–$10k**. **[A15]**
- Cyton + Daisy 16-channel: **$2,499**. **[A03]**
- EEG cap: **$999.99**. **[A04]**
- Analog Discovery 3: **$379**. **[A05]**

Known hardware cash range: **$8,877.99–$13,877.99**. The exact current tES price is quote-only; the $5k–$10k range is a 2024 literature proxy.

Base internal labor: 120 h BME + 80 h EE + 100 h software = **300 h**, worth about **$25.0k**. Downside integration case: 180 h BME + 120 h EE + 160 h software = **460 h**, worth about **$38.4k**.

### What is actually uncertain

The important unknown is not whether a tES device exists. It is the **configured cost of the architecture you actually need**: stimulation channels, electrode set, software, synchronization, safety validation and support.

Current Neuroelectrics documentation shows 8/20/32-channel StarStim tES-EEG products and a quote workflow, but no public numeric list price. **[S35]**

**To turn this into a real quote, request X from Y:** a configuration-specific StarStim quote from Neuroelectrics covering channel count, stimulation modes, electrode set, software/license, synchronization/triggering, support, warranty and lead time.

### Sensitivity

- tES proxy **$5k → $10k**: +**$5k cash**.
- **+120 mixed engineering hours**: material economic-cost increase; use role-specific loaded rates.
- Integrated versus separate systems: **quote delta**, not a fake percentage uplift.

### Decision gate

Do not treat a research tES+EEG build as clinically deployable. The next meaningful gate is **validated synchronization and safe research operation**, followed by the actual institutional/regulatory study path.

### Good for

Research architecture and pre-study funding decisions.

### Not good for

Therapeutic patient treatment, clinical claims, or a manufacturing/quality budget.

---

## D. 20-completer human EEG pilot

**Decision:** How much cash and staff effort does a small human study consume when the EEG system already exists?

### Physical study model

- **20 completed participants**.
- **25 enrolled** to carry a 20% screen-fail/no-show/dropout buffer.
- **1 session per completed participant**.
- **60-minute recording**.
- **2 room-hours per completed participant** for setup/recording/teardown.
- Participant compensation proxy: **$40–$50 per 60-minute session**. **[A18 / S14]**
- Facility proxy: **$75/hour** external academic EEG access. **[A16 / S12]**
- IRB proxy: **$3,500** at Stanford for the specified industry-sponsored clinical-trial category. **[A17 / S13]**
- Existing EEG system and workstation assumed.

### Base cash build

| Line | Formula | Base |
|---|---|---:|
| EEG facility | 20 × 2 h × $75 | $3,000 |
| Participant compensation | 20 × $45 | $900 |
| IRB proxy | 1 × $3,500 | $3,500 |
| Electrodes | 1 pack | $44.99 |
| Gel | 2 × $24.99 | $49.98 |
| Raw + derived storage | 9.66 GB workload × 12 months × $0.023/GB-month historical proxy | $2.67 |
| **Base cash** | | **$7,497.64** |

The storage formula is driven by the study, not an arbitrary “1 TB” placeholder: 20 participants × 1 hour × 32 channels × 500 Hz × 3 bytes/sample × 3× storage multiplier = **9.66 GB**. The $0.023/GB-month number is a dated 2016 AWS proxy, not a current price. **[A19 / S31]**

### Internal labor

120 h PM + 60 h software = **180 h**, worth **$14,037.83** at the central loaded factor, with a burden-band range of about **$12.8k–$15.2k**.

The labor work products are recruitment/screening/coordination/study administration plus data pipeline/QC/analysis. They do **not** include external recruitment-vendor fees or clinical insurance.

### Conditional cash

**Insurance:** **$12k–$25k** planning proxy from a current secondary medical-device clinical-trial benchmark. **[A30 / S29]**

**External online recruitment proxy:** about **$399.90** for 25 one-hour enrolled participants using a $12/hour reward plus Prolific's 33.3% academic/non-profit platform fee. This is a derived **online recruitment** proxy, not an in-person EEG recruitment quote. **[A35 / S34]**

Combined conditional branch: roughly **$12.4k–$25.4k**, but these are separate branches and should not be added blindly to every university study.

**To turn insurance into a real quote, request X from Y:** protocol-specific research/clinical liability or trial insurance quotes from 2–3 specialist brokers using participant count, risk synopsis, geography, coverage limits and dates.

**To turn recruitment into a real quote, request X from Y:** an institution-specific participant-pool or recruitment-vendor SOW from the study office; for online recruitment, generate a current Prolific quote for the exact audience and duration.

### Sensitivity

- **+10 completed participants:** +**$1,950 known cash** at the current facility and compensation proxies, before added study labor.
- **+0.5 room-hour per participant:** +**$750 cash** at the CUNY facility proxy for the existing 20-subject model.
- **Replace Stanford IRB proxy with the actual institution:** budget moves by `actual fee − $3,500`.

### Cash timing

**Month 1:** IRB submission/initial review cash.  
**Month 2:** facility blocks, participant payments, consumables; storage begins as data are created.

### Decision gate

**Gate: 20 usable completed participants.** The money buys a real human dataset, not merely a study authorization. The dominant operational risk is usually staff/facility coordination rather than raw storage cost.

### Good for

Grant planning, staffing, early human-data budgeting, and determining whether the team can afford the study.

### Not good for

A multi-site clinical trial, sponsor-grade insurance plan, or a grant budget with institutional F&A already applied.

---

## E. U.S. 510(k) neurodiagnostic pathway

**Decision:** What order of magnitude should a team reserve for a 510(k)-type regulatory program after a working product and plausible predicate already exist?

### Scope contract

**Included:** current FDA user fee, dated regulatory-preparation proxy, dated QMS implementation proxy, testing proxy, internal product-evidence/regulatory labor.

**Excluded:** original product R&D, manufacturing scale-up, commercial launch, company overhead.

**Conditional:** clinical evidence, extra testing/retesting, establishment registration if triggered.

**Assumed existing:** working product, baseline design inputs, credible predicate candidate.

### Base regulatory workstream

| Workstream | Planning input | Status |
|---|---:|---|
| FDA small-business fee | **$7,163** | Current primary **[A32]** |
| FDA standard fee | **$28,653** | Current primary alternative **[A33]** |
| Regulatory preparation | **$100k** | 2014 ASPE historical proxy **[A26]** |
| QMS / design-control / SOP / risk bundle | **$260k** | 2014 ASPE historical proxy **[A27]** |
| External testing | **$100k** | Historical secondary proxy **[A28]** |

The resulting **minimum credible cash** is **$467,163** if the applicant is eligible for the small-business fee. The **base planning path** is **$488,653** at the standard FDA fee.

The base internal labor model is **650 h**: 250 BME + 150 EE + 150 software + 100 PM = **$52,248.99** at the central loaded factor.

This labor is defined as product evidence generation, engineering V&V support and submission coordination. It is **not** QMS implementation work; otherwise the historical QMS proxy would risk double counting.

### Downside and branch structure

**Testing sensitivity:** replacing the $100k historical testing proxy with a $200k planning branch adds **$100k cash**, producing about **$567k** on the small-business path or **$589k** on the standard-fee path.

**Clinical evidence branch:** **$500k–$1.5M** is shown separately, based on a current secondary early-feasibility / first-in-human benchmark. It is **not in the base 510(k) total**. FDA states clinical data are not needed for most 510(k)s, but whether clinical performance evidence is relevant depends on the device and predicate strategy. **[A29 / S29 / S24]**

**QMS branch:** the $260k QMS input is a historical externalized proxy. If QMS work is performed internally, replace the proxy with a role-by-role work-product estimate rather than adding both.

### Current regulatory boundary

FDA's QMSR became effective **2 February 2026** and incorporates ISO 13485:2016. That establishes the quality-system boundary; it does not tell you the consulting, documentation, verification or audit price. **[S23]**

**To turn testing into a real quote, request X from Y:** a device-specific V&V SOW from 2 qualified labs covering only applicable electrical safety, EMC, software, performance, biocompatibility/sterility, usability and cybersecurity testing.

**To turn QMS into a real quote, request X from Y:** a QMS gap assessment plus implementation SOW covering design controls, risk management, document control, supplier controls and records under QMSR/ISO 13485 from a medical-device quality consultant.

**To turn regulatory preparation into a real quote, request X from Y:** a fixed-fee scope covering intended-use review, predicate analysis, equivalence strategy, submission assembly and one response round from a 510(k) regulatory consultant.

### Cash timing

**Month 1:** regulatory strategy/predicate work begins.  
**Month 2:** QMS/design-control work is the major spend driver.  
**Month 3:** external testing starts.  
**Month 6:** FDA filing fee is triggered at submission.

These months are **planning triggers**, not vendor promises or FDA review deadlines.

### Decision gate

**Gate: regulatory strategy says the pathway is economically justified.** Before paying for large testing packages, confirm intended use, classification, predicate plausibility and what evidence is actually required.

### Good for

Setting a financing envelope after the product exists and the regulatory strategy is credible.

### Not good for

A universal 510(k) price, a clinical-trial budget, or a claim that the FDA fee represents total regulatory cost.

---

## F. Implantable / complex-device boundary

Do **not** extrapolate garage EEG, tES, or small human-pilot economics into an implantable program.

A published U.S. complex therapeutic-device study estimated mean development cost around **$54M in 2018 dollars**, with a very wide uncertainty interval and exclusion of post-approval studies. This is a boundary/context reference, not an implantable BCI quote. **[A31 / S33]**

The economic model changes qualitatively once the program includes sterility, biocompatibility, clinical evidence, manufacturing validation, risk management, supply-chain controls, and post-market obligations.

**To turn this boundary into a real budget, request X from Y:** a device-specific development and clinical plan with work breakdown, manufacturing strategy, regulatory classification and clinical evidence strategy from the program's regulatory/clinical leads plus at least one experienced contract manufacturer and clinical partner.

## 4. Cross-Scenario Cost Drivers

The recurring drivers that most often dominate are:

1. **Engineering hours** — especially integration, firmware/software, data QC and rework.
2. **Hardware architecture/configuration** — a “starting price” is often not the configured research system.
3. **Human-study operations** — facility time, coordination, recruitment and participant throughput.
4. **Testing/QMS scope** — especially once the product becomes regulated.
5. **Structural branches** — whether clinical evidence, external testing, or outsourced quality work is actually required.

Small storage bills are often less important than the staff time needed to clean, verify and analyze the data.

## 5. Biggest Unknowns — Ranked by Decision Impact

| Unknown | Current proxy | Why it matters | Replacement action |
|---|---|---|---|
| 510(k) testing scope | ~$100k historical proxy; test sensitivity to $200k | Can move regulatory cash by $100k+ | Get 2 device-specific V&V SOWs |
| QMS implementation | $260k historical proxy | Potentially the single largest base workstream | Get QMS gap + implementation SOW |
| Clinical evidence requirement | $500k–$1.5M conditional branch | Structural budget jump | Resolve predicate/intended-use question before committing to testing |
| Current tES configuration | $5k–$10k dated proxy | Hardware range is configuration-sensitive | Get exact Neuroelectrics quote |
| University site/IRB pricing | CUNY/Stanford institution-specific proxies | Can alter pilot cash materially | Get actual institution fee schedule |
| Insurance | $12k–$25k current secondary proxy | Often absent from prototype budgets | Get 2–3 broker quotes from protocol summary |
| External recruitment | ~$400 online proxy | Can grow with enrollment and screening | Get institution/recruitment-vendor SOW |

## 6. What To Quote Next

If only five actions are possible before the next funding decision, do these in order:

1. **Regulatory test SOW:** exact applicable tests + quote from two labs.
2. **QMS gap/implementation:** exact deliverables and fixed-fee estimate.
3. **Current hardware configuration:** quote the exact EEG/tES architecture rather than using a starting price.
4. **Actual study institution:** current EEG access, IRB, participant-payment and recruitment policies.
5. **Insurance:** protocol-specific quotes if human-study risk requires coverage.

## 7. Interpretation Rules

- **Current primary** = a current first-party price, fee or government schedule.
- **Dated primary** = authoritative source, but the number is historical.
- **Current secondary** = recent benchmark from a credible secondary source.
- **Historical secondary** = older benchmark retained for direction or boundary-setting.
- **Derived** = arithmetic from explicit sourced inputs.
- **Scenario assumption** = an explicit planning choice, not a fact.
- **Conditional** = not in base cash unless the branch activates.

For university grant planning, keep **direct scientific cost** separate from the institution's **F&A/indirect cost** calculation.

Do not silently convert currencies or historical numbers into current dollars.

## 8. 90-Minute Answer

### Garage prototype

Budget **~$2.2k cash + ~$15k–$18k labor value** for the low-cost sourced stack and 200-hour base build. The cash floor is credible; the labor estimate is the larger planning variable.

### Serious university EEG

Either **~$4.5k** for 60 h of facility access at the CUNY external-academic proxy, or **~$11k–$16k** cash for a 32-channel-class buy using a dated Enobio proxy plus current accessories. The buy decision turns on utilization and local support terms.

### 20-person human EEG pilot

Plan roughly **$7.4k–$7.6k known cash + ~$13k–$15k internal labor value**, with **$12k–$25k insurance** and a possible recruitment branch outside the base. The next 10 completed subjects cost about **$1.95k known cash** before additional labor.

### 510(k)

For a product that already exists and has a credible predicate strategy, a **~$470k–$490k regulatory cash envelope** is a transparent planning proxy when you combine the current FDA fee with the dated regulatory/QMS/testing benchmarks used here. A **$100k testing swing** is plausible within the model, and a clinical-evidence branch can add **$0.5M–$1.5M** without being part of the base 510(k) path.

## 9. Source Registry

The machine-readable source list in `data/sources.csv` preserves publisher, URL, publication/effective date, geography, evidence quality and the specific claim supported. The anchor list in `data/cost_anchors.csv` preserves the amount, unit, configuration, derivation, assumptions, exclusions and replacement action.

<!-- CALC_SNAPSHOT
garage.min_cash=2152.98
garage.base_cash=2197.97
garage.downside_cash=2267.95
university_eeg.access_cash=4500
university_eeg.buy_low_cash=11378.99
university_eeg.buy_high_cash=16378.99
tes_eeg.base_cash=11377.99
tes_eeg.downside_cash=11477.97
pilot.cash=7497.63504287719726562500
pilot.labor=14037.834720
510k.small_business_cash=467163
510k.standard_cash=488653
CALC_SNAPSHOT -->
